Pharmegic Healthcare Limited - Company finances
|
EUR
|
2018
From: 2018-01-18
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 4,547 | 242,426 | 116,277 | 222,146 | 717,083 | 431,062 | 325,800 |
| Profit before tax | - | - | 116,512 | 25,011 | 35,891 | -7,921 | -5,572 | -30,488 |
| Net profit | -454 | 4,342 | 110,685 | 23,760 | 34,096 | -7,921 | -5,572 | -30,488 |
| Equity | 2,180 | 4,649 | 110,787 | 134,546 | 163,214 | 155,291 | 149,719 | 119,231 |
| Liabilities | 320 | 370 | 20,671 | 39,062 | 40,320 | 63,273 | 23,886 | 43,613 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 2,500 | 5,019 | 131,249 | 173,608 | 203,534 | 218,564 | 173,605 | 162,844 |
| Total assets | 2,500 | 5,019 | 131,249 | 173,608 | 203,534 | 218,564 | 173,605 | 162,844 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,876 | 322 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +5231.6% | -52.0% | +91.0% | +222.8% | -39.9% | -24.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -18.2% | 86.5% | 84.3% | 13.7% | 16.8% | -3.6% | -3.2% | -18.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -20.8% | 93.4% | 99.9% | 17.7% | 20.9% | -5.1% | -3.7% | -25.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 95.5% | 45.7% | 20.4% | 15.3% | -1.1% | -1.3% | -9.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 48.1% | 21.5% | 16.2% | -1.1% | -1.3% | -9.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.2 | 0.3 | 0.2 | 0.4 | 0.2 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 4,547 | 220,387 | 116,277 | 222,146 | 717,083 | 431,062 | 279,249 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Pharmegic Healthcare Limited - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-16 | 2026-06-28 | 244.19 |
| 2026-04-20 | 2026-04-20 | 242.64 |
| 2026-03-27 | 2026-03-27 | 245.24 |
| 2026-03-17 | 2026-03-18 | 245.24 |
| 2026-02-18 | 2026-02-25 | 247.84 |
| 2026-01-22 | 2026-02-17 | 2.60 |
| 2026-01-21 | 2026-01-21 | 588.00 |
| 2026-01-16 | 2026-01-20 | 585.40 |
| 2025-11-18 | 2025-12-11 | 252.61 |
| 2025-10-27 | 2025-11-17 | 1.72 |
| 2025-10-26 | 2025-10-26 | 441.56 |
| 2025-10-23 | 2025-10-25 | 443.28 |
| 2025-10-16 | 2025-10-22 | 441.56 |
| 2025-09-16 | 2025-10-15 | 220.78 |
| 2025-07-24 | 2025-08-05 | 2.49 |
| 2025-06-17 | 2025-07-01 | 219.79 |
| 2025-05-16 | 2025-05-22 | 312.55 |
| 2025-05-04 | 2025-05-15 | 91.77 |
| 2025-04-30 | 2025-04-30 | 209.23 |
| 2025-04-28 | 2025-04-29 | 91.77 |
| 2025-04-26 | 2025-04-27 | 89.23 |
| 2025-04-24 | 2025-04-25 | 91.77 |
| 2025-04-16 | 2025-04-23 | 209.23 |
| 2025-03-18 | 2025-03-20 | 428.45 |
| 2025-02-18 | 2025-03-17 | 207.67 |
| 2025-01-16 | 2025-01-21 | 384.79 |
| 2025-01-02 | 2025-01-15 | 188.25 |
| 2024-12-22 | 2024-12-31 | 188.25 |
| 2024-12-17 | 2024-12-20 | 188.25 |
| 2024-11-18 | 2024-11-26 | 191.71 |
| 2024-09-17 | 2024-10-09 | 196.41 |
| 2024-07-24 | 2024-08-01 | 203.33 |
| 2024-07-16 | 2024-07-23 | 198.77 |
| 2024-06-18 | 2024-07-15 | 2.23 |
| 2024-05-16 | 2024-06-11 | 385.69 |
| 2024-04-23 | 2024-05-15 | 189.15 |
| 2024-04-16 | 2024-04-22 | 183.51 |
| 2024-03-18 | 2024-03-26 | 406.97 |
| 2024-03-05 | 2024-03-17 | 210.43 |
| 2024-02-19 | 2024-03-04 | 369.35 |
| 2024-01-23 | 2024-02-18 | 172.81 |
| 2024-01-16 | 2024-01-22 | 171.15 |
| 2023-11-16 | 2023-12-14 | 173.83 |
| 2023-10-17 | 2023-10-18 | 350.41 |
| 2023-09-18 | 2023-10-16 | 171.75 |
| 2023-08-17 | 2023-08-21 | 533.09 |
| 2023-07-26 | 2023-08-16 | 354.43 |
| 2023-07-24 | 2023-07-25 | 354.55 |
| 2023-07-18 | 2023-07-23 | 348.38 |
| 2023-06-16 | 2023-07-17 | 169.72 |
| 2023-05-16 | 2023-05-24 | 531.06 |
| 2023-05-02 | 2023-05-15 | 352.40 |
| 2023-04-27 | 2023-04-28 | 352.40 |
| 2023-04-26 | 2023-04-26 | 348.47 |
| 2023-04-25 | 2023-04-25 | 352.40 |
| 2023-04-18 | 2023-04-24 | 348.47 |
| 2023-03-16 | 2023-04-17 | 169.81 |
| 2023-02-17 | 2023-02-20 | 361.15 |
| 2023-02-06 | 2023-02-16 | 182.49 |
| 2023-01-20 | 2023-02-03 | 182.49 |
| 2023-01-17 | 2023-01-19 | 180.03 |
| 2022-12-20 | 2023-01-16 | 24.76 |
| 2022-12-16 | 2022-12-19 | 284.76 |
| 2022-11-21 | 2022-12-15 | 129.49 |
| 2022-11-17 | 2022-11-18 | 129.49 |
| 2022-10-18 | 2022-10-24 | 292.90 |
| 2022-09-16 | 2022-10-17 | 137.63 |
| 2022-04-25 | 2022-05-02 | 319.57 |
| 2022-04-19 | 2022-04-24 | 316.32 |
| 2022-03-16 | 2022-04-18 | 161.05 |
| 2022-02-22 | 2022-03-15 | 5.78 |
| 2022-02-17 | 2022-02-21 | 285.78 |
| 2022-01-31 | 2022-02-16 | 130.51 |
| 2022-01-18 | 2022-01-30 | 130.31 |
| 2021-12-16 | 2021-12-16 | 130.75 |
| 2021-11-16 | 2021-11-18 | 131.19 |
| 2021-09-16 | 2021-09-21 | 131.55 |
Pharmegic Healthcare Limited - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-11-26 | 2024-11-26 | 434.09 |
| 2024-11-24 | 2024-11-25 | 433.61 |
| 2024-11-20 | 2024-11-23 | 463.61 |
| 2024-11-11 | 2024-11-19 | 462.41 |
| 2024-10-13 | 2024-11-10 | 488.83 |
| 2024-10-09 | 2024-10-12 | 488.41 |
| 2024-10-02 | 2024-10-08 | 487.43 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Pharmegic Healthcare Limited, UAB (company code 304749224) is a Private Limited Liability Company engaged in retail sale of other food. In the latest financial year, 2025, the company generated revenue of €325.8K and recorded a net loss of €30.5K, corresponding to a profit margin of -9.4%. Revenue declined by 24.4% year on year and by 54.6% over two years, indicating a sustained contraction in activity. The loss also widened materially compared with 2023 and 2024, when net losses were €7.9K and €5.6K respectively. Total assets stood at €162.8K at the end of 2025, with equity of €119.2K and liabilities of €43.6K. The equity ratio was 73.2% and debt-to-equity was 0.37, suggesting a relatively strong capital structure despite the operating loss. Asset turnover was 2.00x. Revenue per employee was €325.8K, while profit per employee was -€30.5K.